Clinical Trials Browser

Salivary Gland Neoplasms × Gonadotropin-Releasing Hormone × 90 days × Clear all

NCT04325828 2026-05-08

YATAGARASU

Phase 2 Active not recruiting

31 enrolled 15 charts

Salivary Gland Neoplasms